Regen BioPharma, Inc. Financial Ratios — RGBPP Stock

Profitability (USD)

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-1,195.09	-1,913.15	-1,264.72	-924.19	-817.72	-1,702.78	2,457.79	-1,013.3	251.49	224.3	-259.67	-585.02
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	-23.31	- -	-12.7	-5.69	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	100	100	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	- -	- -	-1,030.87	-2,956.96	-2,282.62	-1,425.78	-687.99	-190.29	-117.28	-144.2	-290.39	-176.37	-143.11
Operating Margin (%)	- -	- -	-1,030.87	-2,956.96	-2,282.62	-1,425.78	-687.99	-190.29	-117.28	-144.2	-290.39	-176.37	-143.11
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	-1,151.41	-3,413.52	-5,308.22	-4,715.2	-2,384.71	3,104.02	-3,951.79	1,037.52	488.89	-282.49	-538.76
Profit Margin (%)	- -	- -	-1,151.41	-3,413.52	-5,308.22	-4,715.2	-2,384.71	2,483.21	-3,951.79	945.59	432.66	-282.49	-538.76
Net Income to Common Margin (%)	- -	- -	-1,151.41	-3,413.52	-5,308.22	-4,715.2	-2,384.71	2,483.21	-3,951.79	945.59	432.66	-282.49	-538.76
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Total Debt	- -	- -	- -	- -	1	1	2	3	4	1	1	1	1
ST Debt	- -	- -	- -	- -	- -	1	2	3	4	1	1	1	1
LT Debt	- -	- -	- -	- -	- -	1	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	- -	-0.18	-0.11	-0.09	-0.28	-1	-2.84	-12.44	-17.85	-3.75	-1.1	-1.9	-3.54
Net Debt/EBITDA	0.36	-0.18	-0.09	-0.08	-0.17	-1	-2.83	-12.44	-14.22	-3.6	-0.92	-1.9	-3.33
Total Debt/EBIT	- -	-0.18	-0.11	-0.09	-0.28	-1	-2.84	-12.44	-17.85	-3.75	-1.1	-1.9	-3.54
Net Debt/EBIT	0.36	-0.18	-0.09	-0.08	-0.17	-1	-2.83	-12.44	-14.22	-3.6	-0.92	-1.9	-3.33
EBITDA to Interest Expense	- -	-319.33	-91.26	-63.7	-4.36	-0.91	-0.44	-0.22	-0.55	-1.62	-11.56	-4.11	-1.61
EBITDA-CapEx/Interest Expense	- -	-319.33	-91.26	-63.7	-4.36	-0.91	-0.44	-0.22	-0.55	-1.62	-11.56	-4.11	-1.61
EBIT to Interest Expense	- -	-319.33	-91.26	-63.7	-4.36	-0.91	-0.44	-0.22	-0.55	-1.62	-11.56	-4.11	-1.61
Interest Expense	- -	- -	- -	- -	1	2	2	1	- -	- -	- -	- -	- -
Common Equity/Total Assets	-446.04	-11,951.07	-1,577.59	-2,157.1	-1,347.95	-8,343.31	-20,121.8	-13,331.68	-1,890.43	-3,649.76	-5,584.72	-12,674.5	-7,897.11
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	-1.62	-2.77	-4.11	-0.03	- -	- -	- -	-0.79	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	33.52	35.2	314.41	5.02	- -	- -	- -	42.31	- -	- -
Total Debt/Equity (%)	- -	-97.44	-229.2	-44.22	-13.19	-15.7	-19.68	-35.51	-26.57	-15.85	-14.8	-15.21	-19.07
Total Debt/Capital (%)	- -	-11.01	-6.86	-3.92	-5.76	-8.96	-12.1	-18.91	-18.58	-6.68	-3.98	-4.04	-5.85
Total Debt/Total Assets (%)	- -	1,185.42	101.04	81.27	73.36	685.24	2,166.98	2,114.55	295.6	227.92	213.57	492.72	436.18
Net Debt to Equity	-100	-97.44	-189.46	-39.99	-8.05	-15.61	-19.61	-35.51	-21.18	-15.22	-12.42	-15.2	-17.96
Net Debt/Capital (%)	18.31	-11.01	-5.6	-3.53	-3.44	-8.9	-12.05	-18.91	-14.27	-6.39	-3.32	-4.04	-5.49
EBITDA	- -	-1	-2	-3	-3	-1	-1	- -	- -	- -	-1	- -	- -
EBITDA-CapEx	- -	-1	-2	-3	-3	-1	-1	- -	- -	- -	-1	- -	- -
Operating Income (Loss)	- -	-1	-2	-3	-3	-1	-1	- -	- -	- -	-1	- -	- -

Liquidity (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Cash Ratio	- -	- -	0.12	0.03	0.05	- -	- -	- -	0.05	0.01	0.02	- -	0.01
Current Ratio	- -	0.08	0.2	0.26	0.08	- -	0.01	0.01	0.07	0.04	0.02	0.03	0.04
Quick Ratio	- -	0.08	0.16	0.17	0.08	- -	0.01	0.01	0.06	0.04	0.02	0.02	0.04
CFO/Avg Current Liab	- -	-10.65	-5.21	-2.99	-0.57	-0.22	-0.05	- -	-0.1	-0.05	-0.03	-0.14	-0.06
Common Equity/Total Assets	-446.04	-11,951.07	-1,577.59	-2,157.1	-1,347.95	-8,343.31	-20,121.8	-13,331.68	-1,890.43	-3,649.76	-5,584.72	-12,674.5	-7,897.11
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	-1.62	-2.77	-4.11	-0.03	- -	- -	- -	-0.79	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	33.52	35.2	314.41	5.02	- -	- -	- -	42.31	- -	- -
Total Debt/Equity (%)	- -	-97.44	-229.2	-44.22	-13.19	-15.7	-19.68	-35.51	-26.57	-15.85	-14.8	-15.21	-19.07
Total Debt/Capital (%)	- -	-11.01	-6.86	-3.92	-5.76	-8.96	-12.1	-18.91	-18.58	-6.68	-3.98	-4.04	-5.85
Total Debt/Total Assets (%)	- -	1,185.42	101.04	81.27	73.36	685.24	2,166.98	2,114.55	295.6	227.92	213.57	492.72	436.18
CFO/Total Liabilities	- -	-532.41	-375.47	-184.52	-30.58	-16.91	-4.38	0.25	-7.69	-7.06	-3.19	-13.97	-5.85
CFO/CapEx	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	- -	-401.36	-52.31	-62.73	-34.39	-188.51	-438.94	-264.83	-40.94	-71.67	-101.5	-223.53	-141.23

Working Capital (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Accounts Receivable Turnover	- -	- -	- -	2.41	2.65	- -	3.09	1.26	1.08	1.01	1.86	4.99	1.58
Days Sales Outstanding	- -	- -	- -	151.48	137.7	- -	118.1	289.31	337.28	362.23	196.17	73.19	231.25
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Cash & Cash Equivalents	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -	- -	- -
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	1	1	2	3	4	1	1	1	1
Enterprise Value	- -	- -	- -	- -	- -	1	2	3	3	1	1	1	1
Total Capital	-1	-1	-3	-7	-12	-16	-18	-14	-19	-19	-19	-20	-20
Total Debt/Capital (%)	- -	-11.01	-6.86	-3.92	-5.76	-8.96	-12.1	-18.91	-18.58	-6.68	-3.98	-4.04	-5.85
Total Debt / EV	- -	1	1.17	1.05	1.58	0.99	0.99	0.98	1.23	1	1.19	1	1.06
EV/Sales	- -	- -	0.99	2.48	4	14.42	19.8	24.07	16.96	5.4	2.68	3.36	4.77
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	1.78	2.75	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	1.78	2.75	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Enterprise Value	- -	- -	- -	- -	- -	1	2	3	3	1	1	1	1
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	- -	-1	-2	-3	-3	-1	-1	- -	- -	- -	-1	- -	- -
TTM Operating Income	- -	-1	-2	-3	-3	-1	-1	- -	- -	- -	-1	- -	- -
TTM Cash Flow to Firm	- -	-1	-1	-2	-1	- -	1	1	-1	- -	- -	-1	- -
TTM Free Cash Flow to Firm	- -	-1	-1	-2	-1	- -	1	1	-1	- -	- -	-1	- -

Multiples (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	- -	- -	- -	1	2	3	3	1	1	1	1
Low Price	- -	- -	- -	2.5	5	1.75	0.32	0.25	0.25	4.25	0.35	0.02	0.01
EV/Sales	- -	- -	0.99	2.48	4	14.42	19.8	24.07	16.96	5.4	2.68	3.36	4.77
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Average	- -	- -	0.99	2.48	4	14.42	19.8	24.07	16.96	5.4	2.68	3.36	4.77
EV/Sales High	- -	- -	0.99	2.48	4	14.42	19.8	24.07	16.96	5.4	2.68	3.36	4.77
EV/Sales Low	- -	- -	0.99	2.48	4	14.42	19.8	24.07	16.96	5.4	2.68	3.36	4.77
EV/EBITDA Average	0.36	-0.18	-0.1	-0.08	-0.18	-1.01	-2.88	-12.65	-14.46	-3.74	-0.92	-1.9	-3.34
EV/EBITDA High	0.36	-0.18	-0.1	-0.08	-0.18	-1.01	-2.88	-12.65	-14.46	-3.74	-0.92	-1.9	-3.34
EV/EBITDA Low	0.36	-0.18	-0.1	-0.08	-0.18	-1.01	-2.88	-12.65	-14.46	-3.74	-0.92	-1.9	-3.34
EV/EBIT Average	0.36	-0.18	-0.1	-0.08	-0.18	-1.01	-2.88	-12.65	-14.46	-3.74	-0.92	-1.9	-3.34
EV/EBIT High	0.36	-0.18	-0.1	-0.08	-0.18	-1.01	-2.88	-12.65	-14.46	-3.74	-0.92	-1.9	-3.34
EV/EBIT Low	0.36	-0.18	-0.1	-0.08	-0.18	-1.01	-2.88	-12.65	-14.46	-3.74	-0.92	-1.9	-3.34
Last Price	- -	- -	- -	30	13.5	4.38	0.75	0.32	21.28	8.75	0.57	0.1	0.04
High Price	- -	- -	- -	150	35	22.5	4.25	2.25	97.1	24.63	10.63	0.64	0.24
Enterprise Value Average	- -	- -	- -	- -	- -	1	2	3	3	1	1	1	1
Enterprise Value High	- -	- -	- -	- -	- -	1	2	3	3	1	1	1	1
Enterprise Value Low	- -	- -	- -	- -	- -	1	2	3	3	1	1	1	1

Shares Outstanding	- -	- -	- -	- -	- -	- -	1	2	6	7	7	11	39
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic EPS, GAAP	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic EPS from Cont Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted EPS, GAAP	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted EPS from Cont Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow per Basic Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash & Equivalents per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Book Value per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Tangible Book Value per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Regen BioPharma, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)